Skip to Main Content

U-CH22

General Characteristics

Age:78
Gender:Female
Disease Origin:Sacral
Disease Status:Recurrent + Metastatic
Metastatic Site(s):Thigh, sacrum, ilium, clavicle, lungs, peritoneum, lymph nodes, adrenal gland, and thyroid
Sample Origin:Pleural effusion
Prior Radiation:Yes
Prior Systemic Therapy:Yes (imatinib, olaparib)
Source:Kevin Mellert
University of Ulm
Notes:This cell line was developed from cells isolated from pleural effusion fluid.

Molecular Features

Cell Morphology: Mostly non-physaliferous
TBXT Expression: Positive
TBXT Localization: Nuclear
CD24 Expression:
HLA Type:
Sequence Data:
SMARCB1 Status: Presumed SMARCB1-null (poorly differentiated)
Validation Results: Validation Report

Growth Conditions

Growth Medium: 400ml IMDM, 100ml RPMI 1640, 50ml FCS, 6ml Pen/Strep, 6ml L-Glutamin
Freeze Medium: 70% complete growth medium supplemented with an additional 20% fetal bovine serum and 10% DMSO
Culture Conditions: Temperature: 37°C
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Subculturing Instructions: Cell Culture Procedures

Publications

Characterized By:
  • Bette S, et al. (2024) Impact of CDK Inhibitors on TBXT Expression in Chordoma Cell Lines Including the First Stable Cell Line of a High-Grade Chordoma. Diagnostics (Basel). PubMed: 38786326.